Cafepharma Today

Memorial Day Weekend 2025
We wish all our US visitors a safe and enjoyable holiday weekend. We remember those who have given their lives to defend and protect our country.

CP Today will resume on Tuesday, May 27

*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Endo Health's New CEO To Reveal Strategy: Good News For Investors?
Seeking Alpha
Monday, April 1, 2013 - 10:44am
tags:
Endo Health Solutions, Pharma CEOs
Another Day, Another Problem For Hospira
Pharmalot
Monday, April 1, 2013 - 10:43am
tags:
Hospira, manufacturing, recalls
Will This Court Decision Be a Thorn in the Side of Novartis?
Wall St. Cheat Sheet
Monday, April 1, 2013 - 10:39am
tags:
Novartis, India, Gleevac, patents, Glivec
Four Factors Driving Amgen's Stock Price To $102
Seeking Alpha
Monday, April 1, 2013 - 10:38am
tags:
Amgen, AbbVie, Bristol-Myers Squibb, JNJ, Merck, Eli Lilly, Pfizer
Novartis loses landmark India patent case on Glivec
Reuters
Monday, April 1, 2013 - 10:32am
tags:
patents, Novartis, India, Gleevec, Glivec
Diabetes Drug Could Rake Hundreds of Millions for J&J
Wall St. Cheat Sheet
Monday, April 1, 2013 - 10:31am
tags:
JNJ, Invokana, diabetes
AP Pharma And Ziopharm: The Differences Between Bad News
Seeking Alpha
Monday, April 1, 2013 - 10:30am
tags:
Ziopharm, AP Pharma, APF530, chemotherapy-induced nausea and vomiting
3 Pharmaceutical Stocks to Sell Now
InvestorPlace
Saturday, March 30, 2013 - 11:04am
tags:
Corcept Therapeutics, Vivus, Cempra
Pfizer May Have To Rethink Xalkori Cost Structure
Seeking Alpha
Saturday, March 30, 2013 - 11:02am
tags:
Pfizer, Xalkori, lung cancer
FDA OKs first-of-a-kind diabetes drug from J&J
Yahoo/AP
Saturday, March 30, 2013 - 11:01am
tags:
JNJ, diabetes, Invokana, type 2 diabetes
This Pharma's Dividend Is Safe for Now
Motley Fool
Saturday, March 30, 2013 - 10:57am
tags:
Eli Lilly
Celgene's Star Drug Revlimid And Its Competitors
Seeking Alpha
Saturday, March 30, 2013 - 10:57am
tags:
Celgene, Revlimid, Multiple Myeloma, JNJ, Velcade, AbbVie, Bristol-Myers Squibb, elotuzumab
Is This Biotech A Value Stock Or Value Trap?
Seeking Alpha
Saturday, March 30, 2013 - 10:41am
tags:
Omeros
Questions That Must Be Answered For The Success Of Probuphine
Seeking Alpha
Saturday, March 30, 2013 - 10:40am
tags:
Probuphine, opiod addiction
3 Humongous Health-Care Stocks This Week
Motley Fool
Saturday, March 30, 2013 - 10:38am
tags:
Repros Therapeutics, Endocyte, Sarepta Therapeutics
Biogen prices new MS drug at discount to key competitors
Reuters
Saturday, March 30, 2013 - 10:37am
tags:
Biogen, Tecfidera, multiple sclerosis, MS
The Oncology Stock to Buy Today
Motley Fool
Saturday, March 30, 2013 - 10:35am
tags:
ONYX Pharmaceuticals
3 Horrendous Health-Care Stocks This Week
Motley Fool
Saturday, March 30, 2013 - 10:34am
tags:
Ziopharm, Idenix, Vanguard Health Systems
Intellect Neurosciences Issues Letter to Shareholders
Yahoo/GlobeNewsWire
Saturday, March 30, 2013 - 10:32am
tags:
Intellect Neurosciences, Conjumab
Discovery Labs Announces Newly-Released Surfaxin (lucinactant) Publications
Yahoo/PR Newswire
Saturday, March 30, 2013 - 10:30am
tags:
Discovery Labs, Surfaxin

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.